UnitedHealth Group (United States)
ORCID: 0000-0002-9253-7539Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 8 papers. Top paper: “Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees”.
David R. Doody, Jennifer J. Wilkes, Laura Becker, Shasank Chennupati, Pamela Morin +4 more
Gary H. Lyman, David R. Doody, Shasank Chennupati, Laura Becker, Pamela Morin +4 more
Lindsey R. Sangaralingham, Henry J. Henk, Nilay D. Shah, Irbaz Bin Riaz, Aaron S. Mansfield +1 more
Brian Kwan, Milli J. Desai, Vinit Nalawade, Kathryn J. Ruddy, Paul C. Nathan +5 more
Ya‐Chen Tina Shih, Bijan J. Borah, Henry J. Henk
Beth Zhou, Vinit Nalawade, Cynthia Gyamfi-Bannerman, Nina Veeravalli, Henry J. Henk +4 more
Anthony H. Kashou, Holly K. Van Houten, K. Roger Cohen, Henry J. Henk, Bernard J. Gersh +7 more
Beth Zhou, Vinit Nalawade, Cynthia Gyamfi‐Bannerman, Nina Veeravalli, Henry J. Henk +4 more